| Remedial Medical Services Inc | |
|
3576 Arlington Ave Ste 205 Riverside CA 92506-3984 | |
| (714) 482-5159 | |
| Not Available |
| Full Name | Remedial Medical Services Inc |
|---|---|
| Speciality | General Practice |
| Location | 3576 Arlington Ave Ste 205, Riverside, California |
| Authorized Official Name and Position | Syed Raza Rizvi (ADMINISTRATOR) |
| Authorized Official Contact | 7144825159 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Remedial Medical Services Inc 3576 Arlington Ave Ste 205 Riverside CA 92506-3984 Ph: (714) 482-5159 | Remedial Medical Services Inc 3576 Arlington Ave Ste 205 Riverside CA 92506-3984 Ph: (714) 482-5159 |
| NPI Number | 1083216998 |
|---|---|
| Provider Enumeration Date | 11/15/2020 |
| Last Update Date | 11/15/2020 |
| Medicare PECOS PAC ID | 3678986890 |
|---|---|
| Medicare Enrollment ID | O20210107002339 |
News Archive
Baby boomers take note: Medicare as your parents have known it is headed for big changes no matter who wins the White House in 2012. You may not like it, but you might have to accept it. Dial down the partisan rhetoric and surprising similarities emerge from competing policy prescriptions by President Barack Obama and leading Republicans such as Wisconsin Rep. Paul Ryan.
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
NicOx S.A. today reported financial results for the nine months ended September 30, 2009.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083216998 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | (* (Not Available)) | Primary |
| Provider Name | Charles Maletz |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1346453628 PECOS PAC ID: 7517926025 Enrollment ID: I20041008000627 |
News Archive
Baby boomers take note: Medicare as your parents have known it is headed for big changes no matter who wins the White House in 2012. You may not like it, but you might have to accept it. Dial down the partisan rhetoric and surprising similarities emerge from competing policy prescriptions by President Barack Obama and leading Republicans such as Wisconsin Rep. Paul Ryan.
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
NicOx S.A. today reported financial results for the nine months ended September 30, 2009.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.
› Verified 2 days ago
| Provider Name | Jesus Lua |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1992776108 PECOS PAC ID: 2961591326 Enrollment ID: I20071207000703 |
News Archive
Baby boomers take note: Medicare as your parents have known it is headed for big changes no matter who wins the White House in 2012. You may not like it, but you might have to accept it. Dial down the partisan rhetoric and surprising similarities emerge from competing policy prescriptions by President Barack Obama and leading Republicans such as Wisconsin Rep. Paul Ryan.
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
NicOx S.A. today reported financial results for the nine months ended September 30, 2009.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.
› Verified 2 days ago
| Provider Name | Rafael A Penunuri |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1831270362 PECOS PAC ID: 1759432396 Enrollment ID: I20090622000595 |
News Archive
Baby boomers take note: Medicare as your parents have known it is headed for big changes no matter who wins the White House in 2012. You may not like it, but you might have to accept it. Dial down the partisan rhetoric and surprising similarities emerge from competing policy prescriptions by President Barack Obama and leading Republicans such as Wisconsin Rep. Paul Ryan.
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
NicOx S.A. today reported financial results for the nine months ended September 30, 2009.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.
› Verified 2 days ago
| Provider Name | Olumide Akingbemi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1841510385 PECOS PAC ID: 4082886304 Enrollment ID: I20111011000274 |
News Archive
Baby boomers take note: Medicare as your parents have known it is headed for big changes no matter who wins the White House in 2012. You may not like it, but you might have to accept it. Dial down the partisan rhetoric and surprising similarities emerge from competing policy prescriptions by President Barack Obama and leading Republicans such as Wisconsin Rep. Paul Ryan.
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
NicOx S.A. today reported financial results for the nine months ended September 30, 2009.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.
› Verified 2 days ago
| Provider Name | Jesus Arenas |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1861429631 PECOS PAC ID: 0648177543 Enrollment ID: I20120425000437 |
News Archive
Baby boomers take note: Medicare as your parents have known it is headed for big changes no matter who wins the White House in 2012. You may not like it, but you might have to accept it. Dial down the partisan rhetoric and surprising similarities emerge from competing policy prescriptions by President Barack Obama and leading Republicans such as Wisconsin Rep. Paul Ryan.
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
NicOx S.A. today reported financial results for the nine months ended September 30, 2009.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.
› Verified 2 days ago
| Provider Name | Maxwell Y Jen |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1154688810 PECOS PAC ID: 3779895891 Enrollment ID: I20150702000667 |
News Archive
Baby boomers take note: Medicare as your parents have known it is headed for big changes no matter who wins the White House in 2012. You may not like it, but you might have to accept it. Dial down the partisan rhetoric and surprising similarities emerge from competing policy prescriptions by President Barack Obama and leading Republicans such as Wisconsin Rep. Paul Ryan.
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
NicOx S.A. today reported financial results for the nine months ended September 30, 2009.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.
› Verified 2 days ago
| Provider Name | Ahmed M Mahdi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467935858 PECOS PAC ID: 9638418528 Enrollment ID: I20190312001674 |
News Archive
Baby boomers take note: Medicare as your parents have known it is headed for big changes no matter who wins the White House in 2012. You may not like it, but you might have to accept it. Dial down the partisan rhetoric and surprising similarities emerge from competing policy prescriptions by President Barack Obama and leading Republicans such as Wisconsin Rep. Paul Ryan.
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
NicOx S.A. today reported financial results for the nine months ended September 30, 2009.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.
› Verified 2 days ago
| Provider Name | Aurelia Whitehead |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558988295 PECOS PAC ID: 7810316353 Enrollment ID: I20200922002247 |
News Archive
Baby boomers take note: Medicare as your parents have known it is headed for big changes no matter who wins the White House in 2012. You may not like it, but you might have to accept it. Dial down the partisan rhetoric and surprising similarities emerge from competing policy prescriptions by President Barack Obama and leading Republicans such as Wisconsin Rep. Paul Ryan.
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
NicOx S.A. today reported financial results for the nine months ended September 30, 2009.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.
› Verified 2 days ago
| Provider Name | Dion Whitehead |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790303964 PECOS PAC ID: 0042475196 Enrollment ID: I20201002002071 |
News Archive
Baby boomers take note: Medicare as your parents have known it is headed for big changes no matter who wins the White House in 2012. You may not like it, but you might have to accept it. Dial down the partisan rhetoric and surprising similarities emerge from competing policy prescriptions by President Barack Obama and leading Republicans such as Wisconsin Rep. Paul Ryan.
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
NicOx S.A. today reported financial results for the nine months ended September 30, 2009.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.
› Verified 2 days ago
| Provider Name | Qais Ayouby |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1154884351 PECOS PAC ID: 9931582608 Enrollment ID: I20220812000382 |
News Archive
Baby boomers take note: Medicare as your parents have known it is headed for big changes no matter who wins the White House in 2012. You may not like it, but you might have to accept it. Dial down the partisan rhetoric and surprising similarities emerge from competing policy prescriptions by President Barack Obama and leading Republicans such as Wisconsin Rep. Paul Ryan.
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
NicOx S.A. today reported financial results for the nine months ended September 30, 2009.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.
› Verified 2 days ago
News Archive
Baby boomers take note: Medicare as your parents have known it is headed for big changes no matter who wins the White House in 2012. You may not like it, but you might have to accept it. Dial down the partisan rhetoric and surprising similarities emerge from competing policy prescriptions by President Barack Obama and leading Republicans such as Wisconsin Rep. Paul Ryan.
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
NicOx S.A. today reported financial results for the nine months ended September 30, 2009.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.
› Verified 2 days ago
Innovative Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4500 Brockton Ave Ste 305, Riverside, CA 92501 Phone: 206-445-9978 Fax: 858-280-3279 | |
Pulmonary Partners Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5790 Magnolia Ave, Suite 201, Riverside, CA 92506 Phone: 951-368-0427 Fax: 951-368-0429 | |
Lyn M Pintelon D.o. Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8990 Garfield St, Ste.6, Riverside, CA 92503 Phone: 951-358-0784 Fax: 951-354-7583 | |
Precision Spinal Care Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4224 Cedar Pine Ct, Riverside, CA 92505 Phone: 909-648-0377 | |
Parkview Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3722 Tibbetts St, Riverside, CA 92506 Phone: 951-784-3770 | |
Orangecrest Medical Group, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4646 Brockton Ave Ste 203, Riverside, CA 92506 Phone: 951-774-2881 Fax: 951-774-2846 | |
Harmony Health Solutions Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5750 Division St Ste 208, Riverside, CA 92506 Phone: 310-560-9292 |